Rigel Pharmaceuticals Inc Logo

Rigel Pharmaceuticals Inc (RIGL): Eigentümerstruktur

Takani Score ?
67.9

Preis (11.09.2026)52W Hoch52W Tief
47,24 US Dollar52,24 US Dollar24,95 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
63 US Dollar11400
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
18.679.86417,499,49

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Rigel Pharmaceuticals Inc
Mitarbeiter 172
Handelsplatz NASDAQ
Ticker Symbol RIGL
IPO Datum 2000-11-29
Adresse 611 Gateway Boulevard, South San Francisco, CA, United States, 94080

Unternehmensführung

RangNamePosition
1Mr. Raul R. RodriguezPresident, CEO & Director
2Mr. Dean L. Schorno CPAExecutive VP & CFO
3Mr. Raymond J. Furey J.D.Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary
4Mr. David A. SantosExecutive VP & Chief Commercial Officer
5Dr. Alison L. Hannah M.D.Executive VP & Chief Medical Officer
6Ms. Julie PatelSenior VP of Human Resources
7Mr. Joseph LasagaExecutive VP & Chief Business Officer
8Mr. Tarek SallamVice President of Marketing

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1Soleus Capital Management, L.P.9,87%87,09 Mio. USD
2BlackRock Inc9,47%83,56 Mio. USD
3Armistice Capital, LLC6,85%60,47 Mio. USD
4State Street Corp6,00%52,92 Mio. USD
5Vanguard Capital Management, LLC4,09%36,10 Mio. USD
6American Century Companies Inc3,97%35,04 Mio. USD
7LSV Asset Management3,86%34,09 Mio. USD
8Acadian Asset Management LLC3,57%31,48 Mio. USD
9Marshall Wace Asset Management Ltd3,20%28,27 Mio. USD
10D. E. Shaw & Co LP2,90%25,63 Mio. USD
11Geode Capital Management, LLC2,36%20,82 Mio. USD
12The Goldman Sachs Group Inc2,35%20,74 Mio. USD
13Qube Research & Technologies1,84%16,25 Mio. USD
14Renaissance Technologies Corp1,81%15,99 Mio. USD
15Nuveen, LLC1,81%15,94 Mio. USD
16CM Management, LLC1,26%11,10 Mio. USD
17Dimensional Fund Advisors, Inc.1,22%10,77 Mio. USD
18Trexquant Investment LP1,16%10,22 Mio. USD
19Two Sigma Investments LLC1,11%9,81 Mio. USD
20Charles Schwab Investment Management Inc0,95%8,35 Mio. USD